Filing Flows › ASP Isotopes (ASPI) › Q2 2025
ASP Isotopes (ASPI) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
ASP Isotopes (ASPI) reported revenue of $1.2M for the second quarter 2025 (Q2 2025), +17% from a year earlier and +9% from the quarter before. Operating margin was -999.1%.
ASP Isotopes, Q2 2025: revenue $1.2M (+17% year over year), operating margin -999.1%, net loss $75.2M, operating cash flow −$7.9M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +9% | +17% |
| Operating profit | −$12.0M | — | — |
| Net earnings | −$75.2M | — | — |
| Operating cash flow | −$7.9M | — | — |
What changed
Revenue was $1.2M in Q2 2025, up 17% year over year and up 9% from the previous quarter.
Gross margin was 47.7%, up 6.6 points from a year earlier. Operating costs exceeded revenue by $12.0M, an operating margin of -999.1%. Operating expenses grew 59% against revenue growth of 17%. The fastest-growing cost line was Research & development (+86%). The quarter ended with a net loss of $75.2M, wider than the previous quarter's $8.5M loss. Net interest and other expense of $63.1M was the main reason.
Operating cash flow was −$7.9M. Non-cash charges added back $530K of depreciation and amortization and $4.4M of share-based compensation. Working capital and other items added $62.3M. Capital expenditures of $1.8M exceeded it, leaving free cash flow of −$9.7M.
Questions
What was ASP Isotopes' revenue in the second quarter 2025?
ASP Isotopes (ASPI) reported revenue of $1.2M for the second quarter 2025 (Q2 2025), +17% from a year earlier and +9% from the quarter before.
Was ASP Isotopes profitable in the second quarter 2025?
Operating loss was $12.0M (-999.1% of revenue) and net loss $75.2M.
Source: ASP Isotopes 10-Q on SEC EDGAR.